Orexo

Orexo develops drugs and digital therapies that meet needs, especially in the area of mental health and diseases related to drug and drug abuse. The products are commercialized by Orexo in the USA or through partners all over the world. The main market is the American market for buprenorphine / naloxone products, where Orexo commercializes the main drug Zubsolv®, for the treatment of opioid dependence. The head office, where research and development work is conducted, is located in Uppsala.